↓ Skip to main content

Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status

Overview of attention for article published in Journal of Hematology & Oncology, May 2015
Altmetric Badge

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
71 Mendeley